Aoyama R, Ito E, Ohnishi A, Izumi Y, Nagata K, Yokoyama M, Kuronuma T, Fujita M
Jpn J Antibiot. 1984 Nov;37(11):2012-4.
Clinical studies on ceftriaxone (Ro 13-9904, CTRX) were carried out and the results were as follows: Twelve patients (acute purulent tonsillitis 1, pneumonia 6, urinary tract infection 5) were treated with CTRX, in doses of 21-48 mg/kg divided 2 times per day for 3.5-8 days intravenously. The overall efficacy rate was 100%. No adverse reactions were observed. No abnormal laboratory data were noted.
进行了头孢曲松（Ro 13 - 9904，CTRX）的临床研究，结果如下：12例患者（急性化脓性扁桃体炎1例，肺炎6例，尿路感染5例）接受CTRX治疗，剂量为21 - 48mg/kg，每日分2次静脉给药，疗程3.5 - 8天。总有效率为100%。未观察到不良反应。未发现实验室数据异常。
